Trial Profile
A pilot study of prospective observational cohort study to assess the profile of OAD dual combination therapy in patients with T2DM in real practice
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 15 Mar 2019
Price :
$35
*
At a glance
- Drugs Glimepiride/metformin (Primary) ; Antihyperglycaemics; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Handok Inc
- 09 Jun 2012 New trial record